Updates in the Treatment of HR+ Breast Cancer - Episode 2
Insights from TAILORx and RxPONDER in Guiding Treatment in Early-Stage HR+ Breast Cancer
Expert breast oncologists examine adjuvant therapy approaches for early-stage hormone receptor-positive breast cancer, emphasizing the distinct treatment strategies and outcomes observed in pre- and post-menopausal patient populations.
Video Player is loading.
Video content above is prompted by the following:
- What other strategies show promise for early-stage HR+ breast cancer?
Related Content:
